SlideShare a Scribd company logo
1 of 34
Modeling Survival After Surgery On
The Metastatic Spine
Ahmer Ghori MD, Dana Leonard BA, Andrew Schoenfeld MD, Ehsan Saadat MD, Mitch B Harris MD
Ahmer K Ghori MD
Harvard University Orthopaedic Surgery Program
My GoalToday
 Review the past and present state of
managing metastatic spine.
 Discuss how our model may improve the
present state.
Historical: No advantage with surgery
Present: Surgery helps
Limitation: Can’t predict post op survival
Who to operate on?
Our Model
Future: Patient specific management
Evolution of
spinal
instrumentation
Patient
Specific
Variables
Predict survival
reliably
Historic Management:Why no surgery ?
 Laminectomy was the only surgical option.
 No difference in laminectomy + radiation versus
radiation alone with regard to:
 pain relief
 ambulation
 sphincter function.
Young et al 1980
Paradigm Shift
 Evolution of modern spinal instrumentation.
Wider decompressions
&
Robust stabilization
Modern Literature
Surgery helps in managing metastatic spine
Pain.
Ambulation.
Maintain independence at end of life.
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. The Lancet.
2005;366(9486):643–648. doi:10.1016/S0140-6736(05)66954-1.
Present Limitations
 Choosing surgical candidates
 Not a reliable process.
 Existing models:
 Do not predict survival reliably !
 Correlation with survival 20-50 %
Ragel, B. T. et al. Life Expectancy and Metastatic Spine Scoring Systems: An Academic Institutional Experience. J Spinal Disord Tech
(2014).
Wang M, Bünger CE, Li H, Wu C, Høy K, Niedermann B, et al. Predictive value of Tokuhashi scoring systems in spinal metastases,
focusing on various primary tumor groups: Evaluation of 448 patients in the Aarhus spinal metastases database. Spine 2012;37: 573-
582.
Harrington Score
Tokuhashi Score
Tomita Score
Tomita et al. Surgical strategy for spinal metastases. Spine (2001) vol. 26 (3) pp. 298-306
Modified Bauer Score
Existing scoring systems do not
capture patient’s overall health state.
Ghori et al 2015
Why can’t we predict survival ?
Let’s consider a hypothetical scenario
Bauer Score: 4
Can we predict post op
survival from a score of 4
alone?
Consider 2 patients
Female
• Breast cancer
• No visceral metastases
• Solitary spine metastasis
Modified Bauer Score 4
Case 1
 First patient is :
• Young
• Can Ambulate
• Normal
nutrition
status.
Modified Bauer Score 4
Case 1
Modified Bauer Score 4: Case 2
 Second patient is:
• Old.
• Cannot ambulate.
• Poor nutritional status.
Modified Bauer Score 4
Case 2
 Both patients have a Bauer score of 4 !
 Differences will affect survival
 Need a model that is more specific.
Existing Models: Shortcoming
VS.
Hypothesis
Model
Quantifies patient
health status
Predict post op
survival reliably
Ghori et al 2015
Methods
 Retrospective review at four participating
institutions (BIDMC, BWH, MGH, Dartmouth).
 Identify patients who had undergone spine surgery
for metastatic disease between 2007 and 2013.
 Over 300 patients across 5 years included.
Ghori et al 2015
Variables we studied
 Main predictors of survival we studied
 Pre-operative modified Bauer score
 Pre- operative ambulatory status
 Pre-operative serum albumin level.
 Pre-operative serum creatinine level.
 Primary tumor type.
 Demographics: age, sex, race.
 Number of comorbidities.
 We coined these “healthiness states”
Ghori et al 2015
Ghori et al 2015: Our Model
 Analyzed all permutations of these three variables.
 Chose combination which has best correlation with survival.
 High Bauer score (3,4): 2 points
 Intact ambulatory status: 1 point
 Normal serum albumin level : 1 point
 Ceiling score of 3.
Ghori et al 2015
Ghori et al 2015: Model
3
2
1
0
Ghori et al 2015
 Our Model was able to explain 74% of the variation
in 1-year survival.
 What does that mean?
 In contrast existing scoring systems : 20- 50 %
correlation with survival
Ragel, B. T. et al. Life Expectancy and Metastatic Spine Scoring Systems: An Academic Institutional Experience. J Spinal Disord Tech (2014).
Wang M, Bünger CE, Li H, Wu C, Høy K, Niedermann B, et al. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various
primary tumor groups: Evaluation of 448 patients in the Aarhus spinal metastases database. Spine 2012;37: 573-582.
Our Model
 Practical advantage ?
 Let us apply it to our two cases.
High modified Bauer
score and
1. Intact ambulation
2. Normal albumin
78% survival
Modified
Bauer Score
(4):
59% survival
Case 1:Bauer 4
High modified Bauer
score BUT
1. CANNOT ambulate
2. Low albumin
32% survival
Modified
Bauer Score
(4):
59% survival
Case 2:Bauer 4
Ghori et al 2015
Modified Bauer Score (4): 59%
No additional heath states: 30 %
Modified Bauer Score (4): 59%
Intact Ambulation/Normal albumin: 78 %
Ghori et al 2015
30% Vs. 78% survival: big difference !
Capture patient health state Tell apart patients predict survival reliably
Our Model: Advantages
 Simple to apply.
 Superior to existing models in predicting survival.
 300 patients in our analysis:
 one of the largest cohorts in literature.
Our Model: Limitations
 Retrospective nature of our data.
 Model developed from surgical patients so may not
be extrapolated to non-surgical patients.
Future Direction
 Studies to validate our model by applying it to:
 Different databases.
 Prospectively studying it.
Managing Spine Metastases
Where did we come from?
Where are we going?
Historical: No benefit with Surgery
Present : Surgery – too much ?
 Who to operate on?
Our Model
Future approach: Improve patient selection
Operate on the RIGHT PATIENT
Evolution of
spinal
instrumentation
Include Patient
“Health State”
Predict survival
reliably

More Related Content

What's hot

Metastatic Tumors of the Spinal Column: Diagnosis and Treatment
Metastatic Tumors of the Spinal Column: Diagnosis and TreatmentMetastatic Tumors of the Spinal Column: Diagnosis and Treatment
Metastatic Tumors of the Spinal Column: Diagnosis and TreatmentGeorge Sapkas
 
Metastatic bone disease: An old dogma and a new insight
Metastatic bone disease: An old dogma and a new insightMetastatic bone disease: An old dogma and a new insight
Metastatic bone disease: An old dogma and a new insightMohamed Abdulla
 
Bone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesBone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesXiu Srithammasit
 
Treatment of bone metastases
Treatment of bone metastasesTreatment of bone metastases
Treatment of bone metastasesCatherine Holborn
 
Lecture metastatic breast carcinoma to the spine (final version)
Lecture metastatic breast carcinoma to the spine (final version)Lecture metastatic breast carcinoma to the spine (final version)
Lecture metastatic breast carcinoma to the spine (final version)Spiro Antoniades
 
Metastatic bone disease
Metastatic bone diseaseMetastatic bone disease
Metastatic bone diseaseSaurabh Chahar
 
Metastatic Bone Disease & Role of Zoledronic Acid
Metastatic Bone Disease & Role of Zoledronic AcidMetastatic Bone Disease & Role of Zoledronic Acid
Metastatic Bone Disease & Role of Zoledronic AcidMRINMOY ROY
 
Radioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesRadioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesSneha George
 
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...Prof Freih Abu Hassan البروفيسور فريح ابوحسان
 
Ewings sarcoma management Chemotherapy trials
Ewings sarcoma management Chemotherapy trialsEwings sarcoma management Chemotherapy trials
Ewings sarcoma management Chemotherapy trialsParag Roy
 
radiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisradiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisfondas vakalis
 
Breast cancer a focus on bone health integrity
Breast cancer  a focus on bone health integrityBreast cancer  a focus on bone health integrity
Breast cancer a focus on bone health integrityMohamed Abdulla
 
Management of malignant spinal cord compression
Management of malignant spinal cord compressionManagement of malignant spinal cord compression
Management of malignant spinal cord compressionShreya Singh
 

What's hot (20)

Metastatic Tumors of the Spinal Column: Diagnosis and Treatment
Metastatic Tumors of the Spinal Column: Diagnosis and TreatmentMetastatic Tumors of the Spinal Column: Diagnosis and Treatment
Metastatic Tumors of the Spinal Column: Diagnosis and Treatment
 
Metastatic bone disease: An old dogma and a new insight
Metastatic bone disease: An old dogma and a new insightMetastatic bone disease: An old dogma and a new insight
Metastatic bone disease: An old dogma and a new insight
 
Bone metastasis
Bone metastasisBone metastasis
Bone metastasis
 
Bone Metastases of Bone Metastases
Bone Metastases of Bone MetastasesBone Metastases of Bone Metastases
Bone Metastases of Bone Metastases
 
Treatment of bone metastases
Treatment of bone metastasesTreatment of bone metastases
Treatment of bone metastases
 
ABC1 - R.E. Coleman - Bone metastases
ABC1 - R.E. Coleman - Bone metastases ABC1 - R.E. Coleman - Bone metastases
ABC1 - R.E. Coleman - Bone metastases
 
Bone Metastases
Bone MetastasesBone Metastases
Bone Metastases
 
Lecture metastatic breast carcinoma to the spine (final version)
Lecture metastatic breast carcinoma to the spine (final version)Lecture metastatic breast carcinoma to the spine (final version)
Lecture metastatic breast carcinoma to the spine (final version)
 
Astro bone mets
Astro bone metsAstro bone mets
Astro bone mets
 
Spinal Metastases
Spinal MetastasesSpinal Metastases
Spinal Metastases
 
Metastatic bone disease
Metastatic bone diseaseMetastatic bone disease
Metastatic bone disease
 
Metastatic bony lesion
Metastatic bony lesionMetastatic bony lesion
Metastatic bony lesion
 
Metastatic Bone Disease & Role of Zoledronic Acid
Metastatic Bone Disease & Role of Zoledronic AcidMetastatic Bone Disease & Role of Zoledronic Acid
Metastatic Bone Disease & Role of Zoledronic Acid
 
Radioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesRadioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastases
 
Spinal Cord Syndrome
Spinal Cord SyndromeSpinal Cord Syndrome
Spinal Cord Syndrome
 
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...
- اورام العظام الخبيثه Bone metastasis-البروفيسور فريح ابوحسان - استشاري اورا...
 
Ewings sarcoma management Chemotherapy trials
Ewings sarcoma management Chemotherapy trialsEwings sarcoma management Chemotherapy trials
Ewings sarcoma management Chemotherapy trials
 
radiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisradiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalis
 
Breast cancer a focus on bone health integrity
Breast cancer  a focus on bone health integrityBreast cancer  a focus on bone health integrity
Breast cancer a focus on bone health integrity
 
Management of malignant spinal cord compression
Management of malignant spinal cord compressionManagement of malignant spinal cord compression
Management of malignant spinal cord compression
 

Similar to Thesis Presentation-Abbreviated version

Breast surgery for Metastatic Breast Cancer : Cochrane Analysis
Breast surgery for Metastatic Breast Cancer : Cochrane Analysis Breast surgery for Metastatic Breast Cancer : Cochrane Analysis
Breast surgery for Metastatic Breast Cancer : Cochrane Analysis Kundan Singh
 
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellThe Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellScottish Cancer Prevention Network
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipEuropean School of Oncology
 
Patients Of Size Nti
Patients Of Size NtiPatients Of Size Nti
Patients Of Size Ntimgobl84462
 
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...Takehiko Ito
 
Outcome of Lumbar Fusion
Outcome of Lumbar FusionOutcome of Lumbar Fusion
Outcome of Lumbar FusionPaul Coelho, MD
 
SCCHN & Weight Poster
SCCHN & Weight PosterSCCHN & Weight Poster
SCCHN & Weight PosterAbby Smith
 
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds
 
Evidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgeryEvidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgerydrpouriamoradi
 
Evidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgeryEvidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgerydrmoradisyd
 
Pharmacologic therapies.docx
Pharmacologic therapies.docxPharmacologic therapies.docx
Pharmacologic therapies.docxwrite5
 
Pmr buzz magazine oct 2020
Pmr buzz magazine oct 2020Pmr buzz magazine oct 2020
Pmr buzz magazine oct 2020mrinal joshi
 
Eller-Florentina JC 10 28 14
Eller-Florentina JC 10 28 14Eller-Florentina JC 10 28 14
Eller-Florentina JC 10 28 14Florentina Eller
 
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...Dr Pradeep Jain Reviews
 
Senior Project FinalWORDPDF
Senior Project FinalWORDPDFSenior Project FinalWORDPDF
Senior Project FinalWORDPDFKai Roach
 
MedicalResearch.com: Medical Research Exclusive Interviews March 17 2015
MedicalResearch.com:  Medical Research Exclusive Interviews March 17 2015MedicalResearch.com:  Medical Research Exclusive Interviews March 17 2015
MedicalResearch.com: Medical Research Exclusive Interviews March 17 2015Marie Benz MD FAAD
 

Similar to Thesis Presentation-Abbreviated version (20)

Breast surgery for Metastatic Breast Cancer : Cochrane Analysis
Breast surgery for Metastatic Breast Cancer : Cochrane Analysis Breast surgery for Metastatic Breast Cancer : Cochrane Analysis
Breast surgery for Metastatic Breast Cancer : Cochrane Analysis
 
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna CampbellThe Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
The Importance of Staying Active after a Cancer Diagnosis | Dr Anna Campbell
 
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipMON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
MON 2011 - Slide 27 - S. Faithfull - Spotlight session - Survivorship
 
Patients Of Size Nti
Patients Of Size NtiPatients Of Size Nti
Patients Of Size Nti
 
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...G112  Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
G112 Ito & Shiromaru (2009). Patients’ coping strategies before and after ab...
 
Article presentation
Article presentationArticle presentation
Article presentation
 
Outcome of Lumbar Fusion
Outcome of Lumbar FusionOutcome of Lumbar Fusion
Outcome of Lumbar Fusion
 
Bariatric ppt
Bariatric pptBariatric ppt
Bariatric ppt
 
SCCHN & Weight Poster
SCCHN & Weight PosterSCCHN & Weight Poster
SCCHN & Weight Poster
 
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptx
 
Evidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgeryEvidence based-medicine-and-cosmetic-surgery
Evidence based-medicine-and-cosmetic-surgery
 
Evidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgeryEvidence based medicine and cosmetic surgery
Evidence based medicine and cosmetic surgery
 
Concept Analysis Presentation
Concept Analysis PresentationConcept Analysis Presentation
Concept Analysis Presentation
 
Pharmacologic therapies.docx
Pharmacologic therapies.docxPharmacologic therapies.docx
Pharmacologic therapies.docx
 
Pmr buzz magazine oct 2020
Pmr buzz magazine oct 2020Pmr buzz magazine oct 2020
Pmr buzz magazine oct 2020
 
Eller-Florentina JC 10 28 14
Eller-Florentina JC 10 28 14Eller-Florentina JC 10 28 14
Eller-Florentina JC 10 28 14
 
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...
Dr Pradeep Jain Reviews, Fortis Hospital - Why, Who, When and What of Weight ...
 
Senior Project FinalWORDPDF
Senior Project FinalWORDPDFSenior Project FinalWORDPDF
Senior Project FinalWORDPDF
 
IJPR.2015.138
IJPR.2015.138IJPR.2015.138
IJPR.2015.138
 
MedicalResearch.com: Medical Research Exclusive Interviews March 17 2015
MedicalResearch.com:  Medical Research Exclusive Interviews March 17 2015MedicalResearch.com:  Medical Research Exclusive Interviews March 17 2015
MedicalResearch.com: Medical Research Exclusive Interviews March 17 2015
 

Thesis Presentation-Abbreviated version

  • 1. Modeling Survival After Surgery On The Metastatic Spine Ahmer Ghori MD, Dana Leonard BA, Andrew Schoenfeld MD, Ehsan Saadat MD, Mitch B Harris MD Ahmer K Ghori MD Harvard University Orthopaedic Surgery Program
  • 2. My GoalToday  Review the past and present state of managing metastatic spine.  Discuss how our model may improve the present state.
  • 3. Historical: No advantage with surgery Present: Surgery helps Limitation: Can’t predict post op survival Who to operate on? Our Model Future: Patient specific management Evolution of spinal instrumentation Patient Specific Variables Predict survival reliably
  • 4. Historic Management:Why no surgery ?  Laminectomy was the only surgical option.  No difference in laminectomy + radiation versus radiation alone with regard to:  pain relief  ambulation  sphincter function. Young et al 1980
  • 5. Paradigm Shift  Evolution of modern spinal instrumentation. Wider decompressions & Robust stabilization
  • 6. Modern Literature Surgery helps in managing metastatic spine Pain. Ambulation. Maintain independence at end of life. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. The Lancet. 2005;366(9486):643–648. doi:10.1016/S0140-6736(05)66954-1.
  • 7. Present Limitations  Choosing surgical candidates  Not a reliable process.  Existing models:  Do not predict survival reliably !  Correlation with survival 20-50 % Ragel, B. T. et al. Life Expectancy and Metastatic Spine Scoring Systems: An Academic Institutional Experience. J Spinal Disord Tech (2014). Wang M, Bünger CE, Li H, Wu C, Høy K, Niedermann B, et al. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various primary tumor groups: Evaluation of 448 patients in the Aarhus spinal metastases database. Spine 2012;37: 573- 582.
  • 10. Tomita Score Tomita et al. Surgical strategy for spinal metastases. Spine (2001) vol. 26 (3) pp. 298-306
  • 12. Existing scoring systems do not capture patient’s overall health state. Ghori et al 2015 Why can’t we predict survival ?
  • 13. Let’s consider a hypothetical scenario Bauer Score: 4 Can we predict post op survival from a score of 4 alone? Consider 2 patients Female • Breast cancer • No visceral metastases • Solitary spine metastasis
  • 14. Modified Bauer Score 4 Case 1  First patient is :
  • 15. • Young • Can Ambulate • Normal nutrition status. Modified Bauer Score 4 Case 1
  • 16. Modified Bauer Score 4: Case 2  Second patient is:
  • 17. • Old. • Cannot ambulate. • Poor nutritional status. Modified Bauer Score 4 Case 2
  • 18.  Both patients have a Bauer score of 4 !  Differences will affect survival  Need a model that is more specific. Existing Models: Shortcoming VS.
  • 19. Hypothesis Model Quantifies patient health status Predict post op survival reliably Ghori et al 2015
  • 20. Methods  Retrospective review at four participating institutions (BIDMC, BWH, MGH, Dartmouth).  Identify patients who had undergone spine surgery for metastatic disease between 2007 and 2013.  Over 300 patients across 5 years included. Ghori et al 2015
  • 21. Variables we studied  Main predictors of survival we studied  Pre-operative modified Bauer score  Pre- operative ambulatory status  Pre-operative serum albumin level.  Pre-operative serum creatinine level.  Primary tumor type.  Demographics: age, sex, race.  Number of comorbidities.  We coined these “healthiness states” Ghori et al 2015
  • 22. Ghori et al 2015: Our Model  Analyzed all permutations of these three variables.  Chose combination which has best correlation with survival.  High Bauer score (3,4): 2 points  Intact ambulatory status: 1 point  Normal serum albumin level : 1 point  Ceiling score of 3. Ghori et al 2015
  • 23. Ghori et al 2015: Model 3 2 1 0
  • 24. Ghori et al 2015  Our Model was able to explain 74% of the variation in 1-year survival.  What does that mean?  In contrast existing scoring systems : 20- 50 % correlation with survival Ragel, B. T. et al. Life Expectancy and Metastatic Spine Scoring Systems: An Academic Institutional Experience. J Spinal Disord Tech (2014). Wang M, Bünger CE, Li H, Wu C, Høy K, Niedermann B, et al. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various primary tumor groups: Evaluation of 448 patients in the Aarhus spinal metastases database. Spine 2012;37: 573-582.
  • 25. Our Model  Practical advantage ?  Let us apply it to our two cases.
  • 26. High modified Bauer score and 1. Intact ambulation 2. Normal albumin 78% survival Modified Bauer Score (4): 59% survival Case 1:Bauer 4
  • 27. High modified Bauer score BUT 1. CANNOT ambulate 2. Low albumin 32% survival Modified Bauer Score (4): 59% survival Case 2:Bauer 4
  • 28. Ghori et al 2015 Modified Bauer Score (4): 59% No additional heath states: 30 % Modified Bauer Score (4): 59% Intact Ambulation/Normal albumin: 78 %
  • 29. Ghori et al 2015 30% Vs. 78% survival: big difference ! Capture patient health state Tell apart patients predict survival reliably
  • 30. Our Model: Advantages  Simple to apply.  Superior to existing models in predicting survival.  300 patients in our analysis:  one of the largest cohorts in literature.
  • 31. Our Model: Limitations  Retrospective nature of our data.  Model developed from surgical patients so may not be extrapolated to non-surgical patients.
  • 32. Future Direction  Studies to validate our model by applying it to:  Different databases.  Prospectively studying it.
  • 33. Managing Spine Metastases Where did we come from? Where are we going?
  • 34. Historical: No benefit with Surgery Present : Surgery – too much ?  Who to operate on? Our Model Future approach: Improve patient selection Operate on the RIGHT PATIENT Evolution of spinal instrumentation Include Patient “Health State” Predict survival reliably